John Jenkins
Patrimonio netto: - $ in data 31/05/2026
Patrimonio netto: - $ in data 31/05/2026
John Kenneth Jenkins is currently Director at Corbus Pharmaceuticals, Inc., Independent Director at Corbus Pharmaceuticals Holdings, Inc. since 2018, and Principal-Drug & Biological Products at Greenleaf Health Inc. since 2019.
Former positions include Director-Acting Division at US Food & Drug Administration from 1992 to 2002, Director-New Drugs at Center for Drug Evaluation & Research from 2002 to 2017, Independent Director at Provention Bio, Inc. from 2020 to 2023, and Assistant Professor at Virginia Commonwealth University Health System.
Education includes a doctorate from the University of Tennessee.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 10/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| CORBUS PHARMACEUTICALS HOLDINGS, INC. | Direttore/Membro del Consiglio | 05/06/2018 |
Greenleaf Health Inc.
Greenleaf Health Inc. Miscellaneous Commercial ServicesCommercial Services Provides FDA regulatory consulting services | Corporate Officer/Principal | 01/02/2019 |
Corbus Pharmaceuticals, Inc.
Corbus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Direttore/Membro del Consiglio | - |
| Società | Posizione | Fine |
|---|---|---|
| PROVENTION BIO, INC. | Direttore/Membro del Consiglio | 27/04/2023 |
Center for Drug Evaluation & Research
Center for Drug Evaluation & Research General GovernmentGovernment Operates agencies for the department of health and human services | Corporate Officer/Principal | 01/01/2017 |
US Food & Drug Administration
US Food & Drug Administration General GovernmentGovernment Operates agencies to protect health and human services | Corporate Officer/Principal | 01/01/2002 |
Virginia Commonwealth University Health System
Virginia Commonwealth University Health System Miscellaneous Commercial ServicesCommercial Services Provides clinical research services for cancer treatment | Corporate Officer/Principal | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 8 |
|---|---|
Corbus Pharmaceuticals, Inc.
Corbus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
University of Tennessee
University of Tennessee Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
US Food & Drug Administration
US Food & Drug Administration General GovernmentGovernment Operates agencies to protect health and human services | Government |
Virginia Commonwealth University Health System
Virginia Commonwealth University Health System Miscellaneous Commercial ServicesCommercial Services Provides clinical research services for cancer treatment | Commercial Services |
Center for Drug Evaluation & Research
Center for Drug Evaluation & Research General GovernmentGovernment Operates agencies for the department of health and human services | Government |
Corbus Pharmaceuticals Holdings, Inc.
Corbus Pharmaceuticals Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases | Health Technology |
Greenleaf Health Inc.
Greenleaf Health Inc. Miscellaneous Commercial ServicesCommercial Services Provides FDA regulatory consulting services | Commercial Services |
Provention Bio, Inc.
Provention Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company that engages in intercepting and preventing immune-mediated diseases including type 1 diabetic activities | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale